Increasing Use of Continuous Glucose Monitors Among Patients With Type 2 Diabetes

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Conclusion: This study seeks to fill a crucial gap in understanding how HCP training influences CGM prescription rates and the associated diabetes management outcomes, ultimately aiming to enhance diabetes care for a vulnerable population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• adults 18 years or older,

• have been diagnosed with T2D at least one year prior to recruitment,

• are a current patient of one of the three participating Innercare Clinics with no -

• plans to discontinue their care at Innercare within the next 6 months,

• can understand and speak in English or Spanish,

• have telephone access,

• do not plan to move out of the area within the next 6 months.

• 18 years or older,

• able to read and write in English,

• currently employed at one of the participating Innercare clinics (Brawley, El Centro, Calexico),

• currently be treating at least one adult patient for T2D, scheduled to complete the CGM toolkit training. Exclusion

• Personnel without experience providing care to adult patients with T2D in primary care settings.

Locations
United States
California
Innercare Inc
RECRUITING
El Centro
Innercare, Inc
RECRUITING
El Centro
Contact Information
Primary
Julie L Pickrel, MPH
jpickrel@sdsu.edu
1+ 619-594-3369
Backup
Nicole Rivera
Nrivera3@sdsu.edu
1+ (760)-768-5549
Time Frame
Start Date: 2024-11-04
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 318
Treatments
Experimental: Healthcare Prescribers Exposed to CGM Prescriber Toolkit Training
Participants in this arm will include qualified healthcare prescribers (MDs, DOs, PAs, NPs, etc.) and staff who treat patients with Type 2 diabetes in primary care settings who will receive in depth training using a study-developed prescriber toolkit. The toolkit covers important information including current clinical practice guidelines, eligibility criteria, provider documentation requirements and scripts for discussing CGM use with their patient population. The impact of the training will be evaluated by examining changes in CGM prescription rates for patients with Type 2 diabetes seen in primary care before and after the training is delivered. Secondarily, Participants will be surveyed pre- and post-training to elicit prescribing knowledge and attitudes towards CGM use.
No_intervention: Healthcare Prescribers Not Exposed to CGM Prescriber Toolkit Training
Participants in this arm are prescribers (MDs, DOs, PAs, NPs, etc.) and staff who will NOT receive in depth training using a study-developed prescriber toolkit.
Related Therapeutic Areas
Sponsors
Collaborators: University of California, Berkeley, National Institute on Minority Health and Health Disparities (NIMHD)
Leads: San Diego State University

This content was sourced from clinicaltrials.gov